1. Groneck P, Gotze-Speer B, Oppermann M, Eiffert H, Speer CP . Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluid of high risk preterm neonates. Pediatrics 1994; 93: 712–718.
2. Pierce MR, Bancalari E . The role of inflammation in the pathogenesis of bronchopulmonary dysplasia. Pediatr Pulmonol 1995; 19: 371–378.
3. Halliday HL, Ehrenkranz RA, Doyle LW . Delayed (>3 Weeks) Postnatal Corticosteroids for Chronic Lung Disease in Preterm Infants (Cochrane Review). The Cochrane Library, Issue 2, 2005. Wiley: Chichester, UK.
4. Halliday HL, Ehrenkranz RA, Doyle LW . Moderately Early (7–14 Days) Postnatal Corticosteroids for Preventing Chronic Lung Disease in Preterm Infants (Cochrane Review). The Cochrane Library, Issue 2, 2005. Wiley: Chichester, UK.
5. Halliday HL, Ehrenkranz RA, Doyle LW . Early Postnatal (<96 Hours) Corticosteroids for Preventing Chronic Lung Disease in Preterm Infants (Cochrane Review). The Cochrane Library, Issue 2, 2005. Wiley: Chichester, UK.